Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein

Clinica Chimica Acta

Volumn 262, Issue 1-2, 1997, Pages 13-27

  Ishii, Junnichi ^a   Nagamura, Youichi ^b   Nomura, Masanori ^a   Wang, Jian Hua ^a   Taga, Shinn ^a   Kinoshita, Masatomo ^a   Kurokawa, Hiroshi ^a   Iwase, Masatsugu ^a   Kondo, Takeshi ^a   Watanabe, Yoshihiko ^a   Hishida, Hitoshi ^a   Tanaka, Takao ^c   Kawamura, Keishiro ^c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Coronary reperfusion; Human heart type cytoplasmic fatty acid binding protein; Myoglobin

Indexed keywords

BIOCHEMICAL MARKER; FATTY ACID BINDING PROTEIN; HEPARIN; MYOGLOBIN; TISSUE PLASMINOGEN ACTIVATOR;

ACCURACY; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY REPERFUSION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; CARRIER PROTEINS; CYTOPLASM; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELIN P2 PROTEIN; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; MYOGLOBIN; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030904488     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)06547-9     Document Type: Article

References (37)

1. Garabedian HD, Gold HK, Yasuda T et al. Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. J Am Coll Cardiol 1988;11:729-734.
2. Lewis BS, Ganz W, Laramee P, Cercek B, Hod H, Shah PK, Lew AS. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1988;62:20-24.
3. Ohman EM, Christenson RH, Califf RM et al. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. Am Heart J 1993;126:819-826.
4. Abe S, Arima S, Yamashita T et al. Early assessment of reperfusion therapy using cardiac troponin T. J Am Coll Cardiol 1994;23:1382-1389.
5. Ellis AK, Little T, Masud ARZ, Liberman HA, Morris DC, Klocke FJ. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. Circulation 1988;78:1352-1357.
6. Abendschein DR, Ellis AK, Eisenberg PR, Klocke FJ, Sobel BE, Jaffe AS. Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma. Coron Art Dis 1991;2:201-212.
7. Zabel M, Hohnloser SH, Köter W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993 ;87:1542-1550.
8. Ishii J, Nomura M, Ando T et al. Early detection of successful coronary reperfusion based on serum myoglobin concentration; comparison with serum creatine kinase isoenzyme MB activity. Am Heart J 1994;128:641-648.
9. Miyata M, Abe S, Arima S et al. Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction. J Am Coll Cardiol 1994;23:1009-1015.
10. Seacord LM, Abendschein DR, Nohara R, Hartzler G, Sobel BE, Jaffe AS. Detection of reperfusion within 1 hour after coronary recanalization by analysis of isoforms of the MM creatine kinase isoenzyme in plasma. Fibrinolysis 1988;2:151-156.
11. Puleo PR, Perryman MB. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms. J Am Coll Cardiol 1991:17:1047-1052.
12. Laperche T, Steg PG, Benessiano J et al. Patterns of myoglobin and MM creatine kinase isdforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion. Am J Cardiol 1992;70:1129-1134.
13. Abe S, Nomoto K, Arima S et al. Detection of reperfusion 30 and 60 minutes after coronary recanalization by a rapid new assay of creatine kinase isoforms in acute myocardial infarction. Am Heart J 1993;125:649-656.
14. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991;24:195-201.
15. Kleine AH, Glatz JFC, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992;116:155-162.
16. Tsuji R, Tanaka T, Sohmiya K et al. Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 1993;41:209-217.
17. Bass NM. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 1988:111:143- 184.
18. Glatz JFC, Van der Vusse GJ. Cellular fatty acid-binding proteins: current concepts and future directions. Mol Cell Biochem 1990;98:237-251.
19. Veerkamp JH, Peeters RA, Maatman RGHJ. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991;1081:1-24.
20. Sylvén C, Jansson E, Book K. Myoglobin content in human skeletal muscle and myocardium: relation to fiber size and oxidative capacity. Cardiovasc Res 1984;18:443-446.
21. Lin L, Sylvén C, Sotonyi P, Somogyi E, Kaijser L, Jansson E. Myoglobin content and citrate synthase activity in different parts of normal human heart. J Appl Physiol 1990:69:899-901.
22. Yoshimoto K, Tanaka T, Sohmiya K et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995;10:304-309.
23. Van Nieuwenhoven FA, Kleine AH, Wodzig KWH et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92:2848-2854.
24. Ishii J, Nomura M, Ando T, Hasegawa H, Kimura M, Kurokawa H, Kondo T, Watanabe Y, Hishida H. Heart fatty acid-binding protein can provide a higher level of accuracy than myoglobin for the early detection of acute myocardial infarction [abstract]. J Am Coll Cardiol 1995;25:147A.
25. Judkins MP. Selective coronary arteriography, part I: a percutaneous transfemoral technic. Radiology 1967;89:815-824.
26. The Thrombolysis in Myocardial Infarction Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Eng J Med 1985;312:932-936.
27. Uji Y, Okabe H, Sugiuchi H, Sekine S. Measurement of serum myoglobin by a turbidimetric latex agglutination method. J Clin Lab Anal 1992;6:7-11.
28. Anderson JL, Rothbard RL, Hackworthy RA et al. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase. J Am Coll Cardiol 1988;11:1153-1163.
29. Chesebro JH, Knatterud G, Roberts R et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-154.
30. Ohkaru Y, Asayama K, Ishii H et al. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acidbinding protein. J Immunol Methods 1995;178:99-111.
31. Roos W, Eymann E, Symannek M et al. Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Methods 1995;183:149-153.
32. Harrison DG, Ferguson DW, Collins SM et al. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation 1984;69:991-994.
33. Wall TC, Mark DB, Califf RM et al. Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study. Am J Cardiol 1989;63:423-428.
34. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction. N Engl J Med 1987;317:1055-1059.
35. Kloner RA, Alker KJ. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation 1984;70:513-521.
36. Hirai T, Fujita M, Sasayama S et al. Importance of coronary collateral circulation for kinetics of serum creatine kinase in acute myocardial infarction. Am J Cardiol 1987;60:446-450.
37. Sohmiya K, Tanaka T, Tsuji R et al. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 1993;25:1413-1426.